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Background
A drug molecule or imaging payload must reach its intended site of action to exert an efficient therapeutic or diagnostic action and to prevent adverse side effects. [1, 2] The delivery of active agents to the target organ or disease loci generally requires negotiation of numerous bio-barriers mainly comprised of cells from different origins. [3] [4] [5] Consequently, there has been a rapid development in novel nano and micro-scale vectors to more efficiently deliver drugs, genetic material, and imaging contrast agents to their target locations. [6] [7] [8] While particulates can be administered locally or systemically through various routes (e.g. dermal, intravenous, oral, pulmonary), their initial performance evaluation includes in vitro studies in cell cultures.
In this work, we use the "on contact" toxicity of PEI as a probe of the dynamics of arrival to the cell surface of the same material in carriers of different sizes. In general, this assessment is very important as the dynamic of arrival can further be translated to multiple biological outputs (toxicity being one of them). It is becoming increasingly evident that nano and micro materials cannot be treated in the same manner as chemical compounds with regards to their safety and efficacy assessment [9] , as their unique physicochemical properties are responsible for unexpected interactions with experimental and biological systems [10, 11] . Despite the wide use of in vitro systems for biological assessment of NPs, the direct measure of cellular dosimetry has largely been overlooked in favour of using overall metrics of exposure, principally particle concentration on a mass [12] , number, or surface area basis. This is due to the difficulties in measuring particle arrival at the cell interface. In this context, below we discuss various tests for evaluation of biological (toxicity/efficacy) responses as well the effects of particles of different sizes on the above.
In general, there is an urgent need in toxicity tests or dose response assays to de-couple the physical effects acting upon a particle from their biological effects so that true biological response to A C C E P T E D M A N U S C R I P T 5 variables such as particle size or shape can be determined. This is particularly important in investigations which are directly comparing cellular responses across multiple materials or materials of different sizes [13] [14] [15] . However, physical effects in a system are commonly ignored and the cellular response observed is thought to be solely biology-driven, which may generally lead to misinterpretation of the obtained results. For instance, cytotoxicity assays investigating the role of cell cycle in cellular uptake and toxicity do not take into account the non-linear delivery rate of nano and micro-particles and consider responses to be uniquely driven by biological changes in the cell during proliferation [16] . In terms of the efficacy, the rate of arrival of an agent to the cell surface is extremely important when comparing therapeutic entities such as low molecular weight drugs, proteins and oligonucleotides adsorbed/conjugated to the surface of the carriers [17, 18] . In this instance, decoupling the kinetic processes of carrier arrival to the cell surface and the ultimate response will allow for better understanding of the mechanism of action of various carriers, their transport in the tissues of interest [19] and ways to improve the therapeutic efficacy. Consequently, many studies have reported an increase in the therapeutic efficacy of a drug when coupled with a nano or micro material [20, 21] or when particles alone have been introduced to cells to cause antitumor [22] or antibacterial activity [23] . Our model can be used to validate the numerous studies performed relating size dependent cellular uptake and biological effect of nano and micro-material in vitro. For instance, in a study [24] which reported a carrier size-dependent increase in cellular concentration of paclitaxel loaded PLGA particles, decoupling the effect of particle arrival from the reported biological effects could shed more lights on the mechanisms underlying the efficacy of the investigated carriers on the cellular level.
The development of a wide range of drug delivery systems, spanning nano, micro and mesoscopic scales, has resulted in a powerful array of therapeutics. Considerable efforts have been invested in the characterisation of these advanced delivery vectors, however the difference in size between systems has numerous effects, limiting the ability to compare their performance. [25] [26] [27] [28] [29] [30] Whilst the
pharmacology of many specific drug delivery vectors is well reported, there is little or no literature on comparative studies, which encompass various scales. Existing reports primarily focus on size [31, 32] or shape [33, 34] changes within a single drug delivery system. The pronounced surface to volume ratio scaling as size is reduced to the nanoscale affects the physical nature of the particles and their biological effects. [35] As an example, a larger size of the carrier can be linked to a better encapsulation capacity, higher weight of particle, faster sedimentation rate and larger total surface area of individual particles but collectively lower surface area per unit weight. have presented experimental evidence that transport to cells of 25-50 nm and 250-500 nm cerium oxide particles is different, depending in the former case on diffusion and the latter case on gravitational settling. [32] This differential transport was shown to affect cellular uptake rates and
toxicity. In an insightful study Wittmaack showed that a unified description of particle-cell interaction can be obtained despite varying experimental factors, provided that the key determinant of cell response in known. This showed that for nanoparticles a universal response curve can be obtained when presented as a function of areal mass density of particles transported to cells. [41] In this study, we aim to provide a general framework for the benchmarking of drug vectors of differing materials across size scales, presenting a unified theory for dose-response for an arbitrary drug delivery vehicle. Our approach is based and validated on experimental data obtained using a model system of cationic polyethylene imine (PEI) based macromolecules (mol-PEI), and surface coated nano-and microparticles (NP-PEI and P-PEI) delivered to Human foreskin fibroblast cells (HFF-1). These delivery vehicles are chosen to span molecular to micro scales and in doing so they account for different modes of delivery to the cell with diffusion dominating molecular transport, diffusion and sedimentation dictating the nanoparticle motion and sedimentation alone being the dominant transport mechanism for the microparticles. As we have previously reported, since PEI has almost immediate biological effects directly related to its contact with the cell membrane, this molecule provides an ideal model for comparing behaviors of various drug vectors. [42, 43] We stress that this is not a biology focused study from which we try to understand the cellular response;
rather, it is a presentation and validation of a technique for comparing the performance of different scales of drug delivery systems. We show that the delivery kinetics of PEI to the cells is highly correlated with the dynamics of cell death and use the benchmarking analysis to obtain a hypothesis that the magnitude of the biological response to PEI is determined by the total number of PEI molecules delivered to the cells by surface attachment to the various delivery vectors.
Methods
Cell culture: Human foreskin fibroblast cells (HFF-1, ATCC® SCRC-1041™) were obtained from American type culture collection (ATCC, Manassas, Virginia, USA). The cells were cultured in 75
cm 2 flasks in a humidified incubator at 37°C with 5% CO 2 in Dulbecco's modified Eagle's medium (DMEM, ATCC) supplemented with 15% fetal bovine serum (FBS, Invitrogen, USA), 4 mM Lglutamine, 1 mM sodium pyruvate and 1% penicillin (50 IU mL -1 ) /streptomycin (50 g mL -1 ).
Delivery vectors:
The tested systems included polyethylenimine (PEI, Mw 25,000, density 1.030 g mL -1 , Sigma Aldrich, USA), PEI modified nanoparticles (NP-PEI) and PEI modified microparticles (µP-PEI). NP-PEI: PEI modified quantum dots (QD), were synthetized as previously described [42, 44] . To obtain µP-PEI, spherical silica beads, (0.9 μm diameter and zeta potential -28.1mV)
were obtained from Polysciences Inc. (USA). The beads were sonicated and washed 3-4 times in DI water (followed by centrifugation at 20,000g for 10 min). Further, the supernatant was removed and the microparticles were oxidized with 10% HNO 3 in DI water for 30 min. Following centrifugation and three washes with isopropyl alcohol (IPA), PEI functionalization was performed using 1mL measure the mean pixel intensity, as pixel intensity can be assumed to be proportional to particle dose at a given time point. The inverse mean pixel intensity of 81 brightfield images of free PEI and P-PEI was used to quantify the amount of free PEI and P-PEI, as these are non-fluorescent and produced a dark area within the image.
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Characterisation of delivery vectors
Details relating to characterisation of delivery vector size and surface charge are presented in Figure 1 and summarised in 
Exposure-response profiles
We begin our presentation of the cell response profiles with the pharmacological standard of an end-point, exposure-response curve. Data is presented in Figure 2 on the % cell death after 24
hours of exposure to the three drug vectors, across a range of concentrations. For each delivery system the assay delivers a full description of the concentration dependent cell response. However a common understanding of all three systems through the fundamental mechanisms that determine their cell interactions cannot be obtained directly. It is clear that there is a widely differing potency, dependent upon the vector size. Whilst this could be anticipated, it is difficult to gain any quantitative insight as the "delivered dose" is determined by counteracting effects -a reduced concentration of larger delivery vectors is linked to increased numbers of PEI cargo molecules per vector. Crucially, the measurements cannot report on any of the processes that drive the pharmacodynamics, for this is a single time-point assay.
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To overcome these limitations we adopt an alternative approach, based on time-lapse imaging of the cells [42] to obtain time-mortality data. [45] This allows observation of the dynamics of cell response as the delivery vector concentration is increased. Results for all 3 vectors, at varying concentration, taken over a 24 hour exposure period are shown in Figure 3 . When the cell response is viewed as a temporal process, the influence of the vector delivery becomes immediately apparent.
The rapid delivery of the relatively heavy microparticles (P-PEI) through sedimentation produces a quick response with cell death rapidly increasing and then plateauing within a few hours, regardless of the exposure concentration. In contrast the lighter nanoparticle and molecule systems show slower and more complex dynamics, the form of which is dependent upon the delivery-vector concentration. This is as expected since the delivery in these cases is driven by both sedimentation and diffusion with the relative weighting of these processes dependent upon particle size and density. [46] The response profile for the P-PEI has a constant form with the % cell death scaling linearly with exposure concentration. This is indicative of a dose-response that is purely delivery dependent with the time to cell death determined by the sedimentation velocity and culture medium height and the maximum % of cells dying controlled by the available particle dose. In all cases there is a saturation in the cell mortality below 100% for lower exposure concentrations and we attribute this to depletion of the delivery vectors from the supply reservoir. [42, 46] Close inspection of the time-mortality curves for NP-PEI and mol-PEI would seem to indicate anomalous results as the time response of the cells is similar whereas the diffusion/sedimentation dynamics of the nanoparticles and molecules should be orders of magnitude different. The response profile is determined by (1) the time dependent arrival of the PEI dose and (2) the susceptibility distribution of the cell population, i.e. the accumulated dose at a particular time point and the heterogeneity in the cells" response to this dose. Thus, to further investigate the results shown in Figure 3 we need to isolate these two factors.
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Delivery vector accumulation dynamics
To decouple the delivery of the PEI vectors from the cell response we assessed their arrival kinetics onto a culture well surface without the presence of cells. Measurement of the relative changes in delivery vector concentration follows from analysis of microscopy images of the well surface. The NP-PEI quantity is assessed by measurement of total nanoparticle fluorescence whereas the P-PEI and mol-PEI vectors are quantified from analysis of bright-field images. Example images, taken for each delivery vector after 24 hours of accumulation, are shown in Figure 4 . The fact that the mol-PEI can be directly imaged using optical microscopy indicates that there is substantial agglomeration occurring within the culture medium and that the delivery vector in this case is not molecular in scale at the point of interaction with cells.
Using the diameter of the PEI agglomerates, measured from the microscopy images, we can estimate the mean number of molecules per agglomerate. The average diameter is 930 nm (N = 50) and they have a surface density of 5.2x10 7 cm -2 , thus the total number of agglomerates across the 9.5 cm 2 area of the culture well is 49.4x10 7 . Assuming that all of the PEI molecules are in an agglomerated form then we estimate a mean number per aggregate of 1.2x10 16 /49.4x10 7 = 2.4x10 7 molecules (total molecule number calculated for 10 M concentration and 2 ml volume). This total number of molecules, N mol is related to the overall agglomerate size, d agg :
where d mol is the mean spacing of molecules in the cluster. In this case, d mol = 3.2 nm, which corresponds closely to typical diameters for molecules of this weight (25 kDa), [47] indicating that the PEI has formed tightly packed agglomerates. The dramatically increased "effective size" of the PEI molecules caused by agglomeration explains the similarity in cellular response dynamics for mol-PEI and NP-PEI seen in Figure 3 . The delivery rate of the approximately micron sized PEI
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agglomerates is similar to the heavier but smaller quantum dots. An approximate estimate of the sedimentation velocity for the two delivery systems confirms that it is of the same order of The full time course data is shown in Figure 5 . In the case of the P-PEI, where the delivery in vitro is sedimentation dominated, the particle velocity is independent of particle concentration and all delivery vectors arrive at the surface within 5 hours. The lighter NP-PEI and mol-PEI systems display an extended characteristic in which the rate of signal increase drops off over time as the vector supply in the solution is reduced. To obtain a reliable metric of the vector accumulation dynamics we fit the data with the equation. [42]   0 1
Where S is the measured signal and S 0 the maximum signal due to all delivery vectors being present at the surface.  is a characteristic "accumulation time" that defines the time frame for particle arrival. It describes the dynamics of the system as described by the relative changes in S, as in all lifetime-based measures  is independent of the absolute scaling of S. Thus  can be obtained through secondary measures that are proportional to vector concentration (e.g. fluorescence or brightfield pixel intensity). The accumulation time effectively parameterises the delivery dynamics by quantifying the particle motion resulting from diffusion and sedimentation with a single metric.
The equation is derived from a consideration of a closed system with a fixed supply reservoir from which particles are delivered to a surface. [42] The measured data plus modelled fits are shown in The formulation and validation of a calibrated vector delivery equation provides a powerful tool with which we can move from exposure metrics to quantification of delivered dose. The measured signal, S in Equation 2 can be replaced by the vector number, N to which it is linearly correlated:
Where C is the exposure concentration of the vector and V the volume of the exposure medium (CV = N o ). Equation 3 can be used to transform time-mortality data into delivered dose-mortality curves using known values of C and V together with  values determined from the data fits in Figure   5 . The results of this transformation for the three delivery vector systems (data in Figure 3 ) are shown in Figure 6 . The cell response is now related to the vector dose accumulated at the cell surface, thus different exposure concentrations (colour-labelled in Figure 6 ) produce a series of curves that lie on the same profile and extend to a maximum length determined by the concentration (maximum possible dose). This is as expected and a demonstration of Haber"s law-the accumulated dose is a product of the concentration of the agent and the duration of exposure. [48] Whilst the form of the delivered dose-mortality curves is similar to the standard exposure-response data taken at t = 24 hours (Figure 2 ) they differ in one very important aspect: the delivered dosemortality curves are time independent. In using Equation 3 to remove the kinetics of vector delivery to the cell surface in vitro we have obtained response profiles that describe the innate biological susceptibility to the exposure agent. If the correct relationship between delivery vector size and PEI potency can now be obtained then transformation of this delivered dose into a determinant of biological effect (toxicity or mortality) will produce a unified, global response curve that describes the % cell death independent of the form of carrier by which the toxin is delivered.
Investigating the controlling factor for cellular response
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The dose-mortality curves shown in Figure 6 are different for the three delivery vehicle systems.
However, in each case it is the same toxic agent, cationic PEI that is causing cell death, thus the differences must stem from the packing of the agent on each delivery vehicle. The data, therefore, describe a secondary factor related to the presentation of the PEI molecules to the cells rather than the primary cell-toxin interaction. However, the delivered dose-mortality curves do provide a means by which various hypotheses on the form of this primary interaction can be investigated. If we can correctly identify the mechanism of toxicity and find the mathematical relationship that links it to the delivered drug vehicle dose then we can transform the individual response curves for different delivery systems into a single, global curve of drug response, independent of the means by which the drug reaches the cell.
The first step in this investigation addresses the fact that the PEI agglomerates when in molecular form. The concentration of the delivered mol-PEI used in Figure 6 must, therefore, be corrected to report the effective agglomerated vector concentration rather than that predicted under the assumption of a monodisperse molecular solution. This is simply done by dividing the delivered dose value by our estimate of the mean number of PEI molecules per agglomerate (N = 2.4x10 7 ).
The results of this transformation are shown in Figure 7A . The role of the delivery vector size now becomes very apparent as the mol-PEI and P-mol systems, which have near equal diameters, show nearly identical dose-mortality profiles. Even with agglomeration the concentration of mol-PEI remains higher than that of the P-mol (maximum concentration of 16,000 fM cf. 300 fM) and so the data extends over the full % range for cell death in this case.
The data in Figure 7A shows that an equivalent cell response is produced by PEI molecules when they are attached to the surface of a micron scale particle and when they aggregate into a molecular cluster of the same dimensions. This observation leads to the hypothesis that it is the availability of PEI at the surface of the delivery vector that determines the level of toxicity. To test this hypothesis
we calculated the mean number of surface PEI molecules per vector using the measured vector diameters (microparticle = 950 nm, molecular agglomerate = 930 nm, nanoparticle = 15 nm) and an assumed PEI spacing of 3.2 nm. The calculated values were then converted into a molar concentration by multiplying by the effective vector dose concentration (independent variable in Figure 7A ). The result of this dose metric transform is shown in Figure 7B . A unified result is indeed obtained with all delivery vector types and exposure concentrations producing a dosemortality curve that sits on the same global profile. This confirms the hypothesis that it is the total number of PEI molecules presented to the cell on a delivery vector surface, which determines the level of cellular toxicity. The curve in Figure 7B is graphical evidence of the potential of this benchmarking approach for comparison of drug delivery vehicles, regardless of their material composition or size, and the extraction of the true therapeutic/toxic interaction of the drug/toxin with cells.
Discussion
Optimal drug delivery necessitates selective use of particular delivery vehicles, chosen from a wide range of candidate designs and materials dependent upon the nature of the drug and its specified target, and so techniques for benchmarking pharmacological performance across systems are essential. This poses a significant challenge in separating the multiple processes and mechanisms that determine a dose-response profile and which are dependent upon the delivery vector characteristics and the toxicity of its cargo. The time resolved analysis that we present provides a measurement based technique for separating these processes.
describe the arrival of delivery vectors at the cell surface, allowing us to transform a timedependence into a dose accumulation. This crucial step separates the processes of drug delivery and drug activity in vitro and avoids the complicated dynamics of particle motion in solution [40] by directly determining the resultant dose without need to consider the delivery process. Using this transformation of data from an exposure-response form to a delivered dose-response profile, comparisons can be made of the effectiveness of different drug delivery vectors, according to their presentation of the drug to cells rather than their efficiency of delivery. This allows an understanding of the influence of drug packaging by a carrier vector upon the response of a biological system. Indeed, when fully implemented the benchmarking procedure can provide a single, global drug response metric that identifies the determinant of drug potency and quantifies its influence according to the chosen carrier vector.
The implementation of delivery vector benchmarking presented here has allowed us to compare the free delivery of a cationic molecule to carrier-based delivery using nano and microscale particles.
The technique enables us to infer the presence of agglomeration of the free molecules from the time-resolved cellular response data and to identify the total number of molecules attached to the delivery vector surface as the primary factor determining cell death. The protocol can be implemented across a wide range of delivery vectors, regardless of morphology, scale and composition and is reliant only on the ability to perform time-resolved cellular response studies.
Wider adoption of this approach would allow multiscale, cross-material comparisons of drug delivery vectors and optimisation of therapeutic effect based on analysis of the primary mechanism of drug action rather than secondary factors such as packing density on the delivery vehicle or the efficiency and speed of delivery. A C C E P T E D M A N U S C R I P T
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Graphical Abstract
Many of the key advances in Nanomedicine relate to the concept of delivery of a drug via a secondary carrier -a delivery vector. Here we present an experimental approach that allows quantitative comparison of delivery vectors across scales. This allows detailed analysis and discrimination of the relative roles of the carrier and the drug in determining cell response.
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